3,792 results match your criteria JACC: Cardiovascular Interventions [Journal]


Inside the "Razor Effect": Lessons From Optical Coherence Tomography-What Does Angiography Hide?

JACC Cardiovasc Interv 2018 Dec 7. Epub 2018 Dec 7.

Unità Operativa Complessa di Cardiologia, Ospedale San Francesco, Nuoro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.09.038DOI Listing
December 2018

A New Concern: Persistent Coronary Artery Compression After Balloon Testing During Transcatheter Pulmonary Valve Replacement.

JACC Cardiovasc Interv 2018 Dec 7. Epub 2018 Dec 7.

The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.033DOI Listing
December 2018
1 Read

Three-Dimensional Aortic Model to Create a Fenestrated Stent Graft for the Urgent Treatment of a Paravisceral Penetrating Aortic Ulcer.

JACC Cardiovasc Interv 2018 Dec 7. Epub 2018 Dec 7.

Department of Neurosurgery, University of Leipzig, Leipzig, Germany; Fraunhofer Institute for Machine Tools and Forming Technology, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.024DOI Listing
December 2018

Percutaneous Aortic-to-Right Atrial Fistula Closure as a Complication of Surgical Aortic Valve Replacement.

JACC Cardiovasc Interv 2018 Dec 7. Epub 2018 Dec 7.

Division of Cardiology, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.039DOI Listing
December 2018

Spontaneous Left Anterior Descending Coronary Artery Dissection in a Teenager.

JACC Cardiovasc Interv 2018 Dec 7. Epub 2018 Dec 7.

Istituto Auxologico Italiano, IRCCS, Department of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Milan, Italy; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.09.037DOI Listing
December 2018

Occlusion of an Extremely Large Left Atrial Appendage Using the "Double-LAmbre Technique".

JACC Cardiovasc Interv 2018 Dec 7. Epub 2018 Dec 7.

Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong SAR, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.015DOI Listing
December 2018

Completely Percutaneous Transaxillary Aortic Valve Implantation Under Local Anesthesia: A Minimalist Alternative Access Approach.

JACC Cardiovasc Interv 2018 Dec 7. Epub 2018 Dec 7.

Department of Interventional Cardiology, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.041DOI Listing
December 2018

Volume and the Ever Increasing Standard of Quality Heart Valve Care.

JACC Cardiovasc Interv 2018 Dec 7. Epub 2018 Dec 7.

Intermountain Heart Institute at Intermountain Medical Center, Murray, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.11.011DOI Listing
December 2018

Asymmetric Ventricular Foreshortening of Sapien-3 Transcatheter Heart Valve Associated With Leaflet Subclinical Thrombosis.

JACC Cardiovasc Interv 2018 Dec 7. Epub 2018 Dec 7.

Cardiovascular Institute, Hospital Clínico San Carlos, IdISSC, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.010DOI Listing
December 2018

Individual Operator Experience and Outcomes in Transcatheter Aortic Valve Replacement.

JACC Cardiovasc Interv 2018 Dec 7. Epub 2018 Dec 7.

Department of Cardiothoracic Surgery, Weill Cornell Medical College, New York, New York. Electronic address:

Objectives: The aim of this study was to assess the impact of individual operator experience on transfemoral transcatheter aortic valve replacement (TAVR) outcomes.

Background: TAVR volume-outcome relationships have not been evaluated at the individual operator level.

Methods: New York Statewide Planning and Research Cooperative System data from 8,771 transfemoral TAVR procedures performed by 207 operators between 2012 and 2016 were analyzed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.030DOI Listing
December 2018
1 Read

Functional Assessment and Acute Coronary Syndrome.

JACC Cardiovasc Interv 2018 Dec;11(23):2433-2434

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.09.004DOI Listing
December 2018

First-in-Human Images of Coronary Atherosclerosis and Coronary Stents Using a Novel Hybrid Intravascular Ultrasound and Optical Coherence Tomographic Catheter.

JACC Cardiovasc Interv 2018 Dec;11(23):2427-2430

Sunnybrook Research Institute, Schulich Heart Program, University of Toronto, Toronto, Ontario, Canada; Conavi Medical, North York, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.09.022DOI Listing
December 2018

Does Endovascular Thrombectomy for Ischemic Stroke Impact 30-Day Readmissions?

JACC Cardiovasc Interv 2018 Dec;11(23):2425-2426

Department of Neurology, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.019DOI Listing
December 2018

30-Day Readmissions After Endovascular Thrombectomy for Acute Ischemic Stroke.

JACC Cardiovasc Interv 2018 Dec;11(23):2414-2424

Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, Massachusetts. Electronic address:

Objectives: The authors sought to investigate the incidence, predictors, and causes of 30-day nonelective readmissions after endovascular thrombectomy (EVT).

Background: Randomized trials have demonstrated that EVT improves outcomes in patients with acute ischemic stroke.

Methods: The Nationwide Readmissions Database, years 2013 and 2014, was used to identify hospitalizations for a primary diagnosis of acute ischemic stroke during which patients underwent EVT, with or without intravenous thrombolysis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.09.006DOI Listing
December 2018

A New Milestone in Carotid Stenting?

JACC Cardiovasc Interv 2018 Dec;11(23):2412-2413

Division of Cardiology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.08.010DOI Listing
December 2018

Use of Dual-Layered Stents in Endovascular Treatment of Extracranial Stenosis of the Internal Carotid Artery: Results of a Patient-Based Meta-Analysis of 4 Clinical Studies.

JACC Cardiovasc Interv 2018 Dec;11(23):2405-2411

Division of Cardiology, Department of Advanced Biomedical Sciences, University of Naples "Federico II," Naples, Italy.

Objectives: The aim of this study was to evaluate the clinical efficacy of dual-layered mesh-covered carotid stent systems (DLS) for carotid artery stenting (CAS).

Background: The need to minimize the risk for plaque debris prolapsing between stent struts following CAS has resulted in the development of DLS. Small clinical studies evaluating 2 available devices, Roadsaver and CGuard, have been recently published; none of these studies is sufficiently powered to test the role of common risk factors on the occurrence of stroke at 30 days post-CAS. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.06.047DOI Listing
December 2018

A First-in-Human Evaluation of a Novel Mesh-Covered Stent for Treatment of Carotid Stenosis in Patients at High Risk for Endarterectomy: 30-Day Results of the SCAFFOLD Trial.

JACC Cardiovasc Interv 2018 Dec;11(23):2396-2404

Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania.

Objectives: The primary purpose of this study was the composite of major adverse events through 30 days post-index procedure or ipsilateral stroke from 30 days to 1 year (365 days). Presented here is the composite of death, stroke, and myocardial infarction (MI) through 30 days.

Background: Rates of minor stroke have been higher with carotid artery stenting (CAS) compared with carotid endarterectomy (CEA). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.07.040DOI Listing
December 2018

Value of Drug-Coated Balloons in Small-Vessel Disease: Have They Come of Age?

Authors:
Antonio Serra

JACC Cardiovasc Interv 2018 Dec;11(23):2393-2395

Interventional Cardiology Unit, Cardiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.018DOI Listing
December 2018

Drug-Coated Balloon Versus Drug-Eluting Stent for Small-Vessel Disease: The RESTORE SVD China Randomized Trial.

JACC Cardiovasc Interv 2018 Dec;11(23):2381-2392

Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China. Electronic address:

Objectives: The aim of this study was to evaluate the angiographic efficacy and clinical outcomes of the Restore paclitaxel-coated balloon in a randomized trial designed to enable its approval with an indication for small-vessel disease (SVD).

Background: Higher rates of restenosis and stent thrombosis limit the effectiveness of drug-eluting stent (DES) treatment of SVD. Whether a drug-coated balloon (DCB)-only strategy is effective in de novo SVD is not yet established. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.09.009DOI Listing
December 2018

Drug-Coated Balloons for In-Stent Restenosis: A Fierce Fight for a "Me-Too" Space.

Authors:
Juan F Granada

JACC Cardiovasc Interv 2018 Dec;11(23):2378-2380

Cardiovascular Research Foundation, Columbia University Medical Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.029DOI Listing
December 2018

Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial.

JACC Cardiovasc Interv 2018 Dec;11(23):2368-2377

Catheterization Laboratories, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China. Electronic address:

Objectives: The aim of the present study was to evaluate the angiographic efficacy, clinical safety, and effectiveness of the Restore paclitaxel-coated balloon in a randomized trial designed to enable the approval of the new device in China.

Background: Drug-coated balloon (DCB) angioplasty offers an effective treatment for in-stent restenosis. Restore is a new DCB with a SAFEPAX shellac-ammonium salt excipient that can avoid drug washing off during catheter delivery to the target lesion site. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.09.010DOI Listing
December 2018

The Era of Drug-Coated Balloons: Are All Created Equal?

JACC Cardiovasc Interv 2018 Dec;11(23):2365-2367

Weill Cornell Medical College, NewYork-Presbyterian Hospital, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.001DOI Listing
December 2018

Sustainable Antirestenosis Effect With a Low-Dose Drug-Coated Balloon: The ILLUMENATE European Randomized Clinical Trial 2-Year Results.

JACC Cardiovasc Interv 2018 Dec;11(23):2357-2364

Center for Diagnostic Radiology & Minimally Invasive Therapy, The Jewish Hospital, Berlin, Germany.

Objectives: The aim of this study was to assess the safety and effectiveness of a next-generation low-dose drug-coated balloon (DCB) designed to optimize the amount of drug transferred into the vessel wall and to maximize the amount of time the drug resides in the vessel wall.

Background: Several randomized controlled studies evaluating various DCBs have demonstrated a significantly higher patency rate compared with noncoated percutaneous transluminal angioplasty balloons at 1 year. However, the data are limited and vary by DCB at longer follow-up time points. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.08.034DOI Listing
December 2018

The CHOICE Between Self-Expanding and Balloon-Expandable Valves for Transcatheter Aortic Valve Replacement.

Authors:
Philippe Pibarot

JACC Cardiovasc Interv 2018 Nov 23. Epub 2018 Nov 23.

Institut Universitaire de Cardiologie et de Pneumologie de Québec/Québec Heart & Lung Institute, Department of Medicine, Laval University, Québec, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.003DOI Listing
November 2018

Transcatheter Tricuspid Valve Repair With a Novel Cinching System.

JACC Cardiovasc Interv 2018 Nov 23. Epub 2018 Nov 23.

Interventional Cardiology Unit, AZ Sint-Jan Hospital, Brugge, Belgium. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.09.019DOI Listing
November 2018
1 Read

Lex Talionis - Valve-for-a-Valve: Transcatheter Pulmonary Valve Replacement for Bioprosthetic Valve Dysfunction: An Ode to the Hammurabi Code.

JACC Cardiovasc Interv 2018 Nov 23. Epub 2018 Nov 23.

Cardiac Unit, Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.09.012DOI Listing
November 2018

Repeat Pulmonary Valve Replacement: Similar Intermediate-Term Outcomes With Surgical and Transcatheter Procedures.

JACC Cardiovasc Interv 2018 Nov 23. Epub 2018 Nov 23.

Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia. Electronic address:

Objectives: This study compares 30-day, 1-year, and 3-year echocardiographic findings and clinical outcomes of transcatheter pulmonary valve-in-valve replacement (TPVR) and repeat surgical pulmonary valve replacement (SPVR).

Background: In patients with adult congenital heart disease and previous pulmonary valve replacement (PVR) who require redo PVR, it is unclear whether TPVR or repeat SPVR is the preferred strategy.

Methods: We retrospectively identified 66 patients (TPVR, n = 36; SPVR, n = 30) with bioprosthetic pulmonary valves (PVs) who underwent either TPVR or repeat SPVR at Emory Healthcare from January 2007 to August 2017. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.07.042DOI Listing
November 2018
1 Read

Bioprosthetic Valve Performance After Transcatheter Aortic Valve Replacement With Self-Expanding Versus Balloon-Expandable Valves in Large Versus Small Aortic Valve Annuli: Insights From the CHOICE Trial and the CHOICE-Extend Registry.

JACC Cardiovasc Interv 2018 Nov 23. Epub 2018 Nov 23.

The Heart Center, Segeberger Kliniken (Academic Teaching Hospital of the Universities of Kiel, Lübeck, and Hamburg), Bad Segeberg, Germany; Cardiology Department, Heart Center Leipzig - University Hospital, Leipzig, Germany.

Objectives: The aim of this study was to compare self-expanding and balloon-expandable transcatheter heart valves (THVs) in large versus small aortic valve annuli.

Background: The degree of THV oversizing varies according to annular size, and this can modify the hemodynamic performance of self-expanding and balloon-expandable THVs.

Methods: Patients undergoing transcatheter aortic valve replacement in the randomized CHOICE (Comparison of Transcatheter Heart Valves in High Risk Patients With Severe Aortic Stenosis: Medtronic CoreValve vs Edwards SAPIEN XT) trial (CoreValve [CV], n = 120; SAPIEN XT [SXT], n = 121) and the nonrandomized CHOICE-Extend registry (Evolut R [ER], n = 100; SAPIEN 3 [S3], n = 334) were compared for THV performance by echocardiography (in all patients) and by cardiac magnetic resonance imaging (MRI) regurgitant fraction (RF) (in a subgroup of patients). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.07.050DOI Listing
November 2018
2 Reads

Multiplane Intracardiac Echocardiography: A Novel System to Guide Percutaneous Tricuspid Repair.

JACC Cardiovasc Interv 2018 Nov 23. Epub 2018 Nov 23.

Heart and Vascular Center, University of Virginia, Charlottesville, Virginia; Advanced Cardiac Valve Center, University of Virginia, Charlottesville, Virginia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.09.039DOI Listing
November 2018
1 Read

Simultaneous Congenital Anomaly, Stenosis, and Compression: An Unexpected Trinity of Vascular Conditions.

JACC Cardiovasc Interv 2018 Nov 23. Epub 2018 Nov 23.

Department of Cardiology, Elias Emergency University Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.06.020DOI Listing
November 2018

The Wisdom of Restraint.

Authors:
Richard A Schatz

JACC Cardiovasc Interv 2018 Nov;11(22):2342

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.08.027DOI Listing
November 2018

Newer Generation Transcatheter Heart Valve Devices: Moving FORWARD.

Authors:
Danny Dvir

JACC Cardiovasc Interv 2018 Nov;11(22):2335-2336

University of Washington, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.007DOI Listing
November 2018
1 Read

1-Year Outcomes With the Evolut R Self-Expanding Transcatheter Aortic Valve: From the International FORWARD Study.

JACC Cardiovasc Interv 2018 Nov;11(22):2326-2334

Department of Innovative Interventions in Cardiology, University of Bonn, Bonn, Germany.

Objectives: This study sought to report the 1-year safety and efficacy outcomes in the FORWARD (CoreValve Evolut R FORWARD) study following transcatheter aortic valve replacement (TAVR) with the next-generation Evolut R device (Medtronic, Minneapolis, Minnesota) in routine clinical practice.

Background: The FORWARD study reported low incidences of mortality, disabling stroke, and significant paravalvular leak following TAVR in routine clinical practice at 30 days. Longer-term results in large patient populations with the Evolut R self-expanding, repositionable transcatheter heart valve (THV) are lacking. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.07.032DOI Listing
November 2018
3 Reads

Choosing a Self-Expanding Transcatheter Heart Valve in 2018: Is it Worth it to "Go PRO"?

JACC Cardiovasc Interv 2018 Nov;11(22):2323-2325

Heart Center Bonn, Department of Medicine II, University Hospital Bonn, Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.08.014DOI Listing
November 2018
1 Read

The Latest Evolution of the Medtronic CoreValve System in the Era of Transcatheter Aortic Valve Replacement: Matched Comparison of the Evolut PRO and Evolut R.

JACC Cardiovasc Interv 2018 Nov;11(22):2314-2322

University Hospital Düsseldorf, Medical Faculty, Division of Cardiology, Pulmonology and Vascular Medicine, Düsseldorf, Germany.

Objectives: The aim of this study was to investigate the hemodynamic and clinical performance of the Evolut PRO compared with its direct predecessor, the Evolut R.

Background: Recently, the newest commercially available generation of the self-expandable Medtronic CoreValve prosthesis, the CoreValve Evolut PRO, was introduced to the market. This prosthesis is based on the previous Evolut R model and specifically designed to mitigate paravalvular leakage. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.07.023DOI Listing
November 2018
8 Reads

Invasive Cardiac Procedures Increase Bleeding in Frail Patients With Acute Myocardial Infarction: A Call to Action.

Authors:
John A Bittl

JACC Cardiovasc Interv 2018 Nov;11(22):2297-2299

Interventional Cardiology Group, Florida Hospital Ocala (formerly Munroe Regional Medical Center), Ocala, Florida. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.10.013DOI Listing
November 2018

The Association of Frailty With In-Hospital Bleeding Among Older Adults With Acute Myocardial Infarction: Insights From the ACTION Registry.

JACC Cardiovasc Interv 2018 Nov;11(22):2287-2296

Duke Clinical Research Institute, Durham, North Carolina.

Objectives: The aim of this study was to determine whether frailty is associated with increased bleeding risk in the setting of acute myocardial infarction (AMI).

Background: Frailty is a common syndrome in older adults.

Methods: Frailty was examined among AMI patients ≥65 years of age treated at 775 U. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.08.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260951PMC
November 2018
2 Reads

Chronic Total Occlusion Revascularization and Quality-of-Life Improvement Across All Levels of Left Ventricular Function: Many Questions Still Unanswered.

Authors:
Luis A Guzman

JACC Cardiovasc Interv 2018 Nov;11(22):2284-2286

Division of Cardiology, Virginia Commonwealth University, Richmond, Virginia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.08.021DOI Listing
November 2018

Health Status Benefits of Successful Chronic Total Occlusion Revascularization Across the Spectrum of Left Ventricular Function: Insights From the OPEN-CTO Registry.

JACC Cardiovasc Interv 2018 Nov;11(22):2276-2283

University of Washington, Seattle, Washington. Electronic address:

Objectives: This study sought to describe the association between chronic total occlusion (CTO) revascularization (CTO percutaneous coronary intervention [PCI]) and health status in patients with and without cardiomyopathy.

Background: Prior PCI trials for cardiomyopathy have excluded CTO patients. Whether patients with reduced left ventricular ejection fraction (LVEF) receive similar health status benefit from CTO-PCI compared with patients with normal LVEF is unclear. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.07.058DOI Listing
November 2018
1 Read

Nonculprit Lesion Intervention: 1 Step Closer to the COMPLETE Answer?

Authors:
Shamir R Mehta

JACC Cardiovasc Interv 2018 Nov;11(22):2274-2275

Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.08.029DOI Listing
November 2018

Predictors and Outcomes of Staged Versus One-Time Multivessel Revascularization in Multivessel Coronary Artery Disease: Insights From the VA CART Program.

JACC Cardiovasc Interv 2018 Nov;11(22):2265-2273

Department of Medicine, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina; Durham Veterans Affairs Medical Center, Durham, North Carolina. Electronic address:

Objectives: The aim of this study was to determine predictors and outcomes associated with staged percutaneous coronary intervention (PCI) versus one-time multivessel revascularization (OTMVR) in patients with multivessel coronary artery disease.

Background: Prior observational studies have not evaluated predictors and outcomes of staged PCI versus OTMVR in a heterogenous population of patients with multivessel coronary artery disease who undergo multivessel revascularization.

Methods: Data from the Veterans Affairs (VA) CART (Clinical Assessment, Reporting, and Tracking) Program were used to evaluate patients who underwent PCI of >2 vessels between October 1, 2007, and September 3, 2014. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.07.055DOI Listing
November 2018

The Arc of the Research Universe Is Long, But it Bends Toward the Truth.

Authors:
Somjot S Brar

JACC Cardiovasc Interv 2018 Nov;11(22):2262-2264

Regional Department of Cardiac Catheterization, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2018.08.026DOI Listing
November 2018
1 Read